ATLX

Atlas Lithium is not a business you can value on fundamentals — it is a development-stage call option on a single project. FY2025 'revenue' was $121K (down 83.8%), gross profit was actually negative (-$59.4K), and the company posted a -$28.1M net loss on a -$172M accumulated deficit. The P/S of 831.6 and operating margin of -26,074.8% are mathematical artifacts of a company with essentially no sales, so the valuation lens offers no support either way. Management is explicit in its own filing: 'We are an exploration stage company, and there is no guarantee that our properties will result in the commercial extraction of mineral deposits,' and warns its properties 'may not contain any reserves.' That is the central problem — there is no proven, producing asset behind the $101M market cap.

The balance sheet buys time but not safety. Cash of $35.9M (up 131%) against operating cash burn of -$22.2M plus $6.09M capex means roughly 12–18 months of runway before the next raise. The funding mechanism is dilution: shares outstanding jumped 59.9% in one year and stockholders' equity rose 144% almost entirely from issuance, not earnings. The filing leans hard on this — the company 'depend[s] on our ability to successfully access the capital and financial markets' and concedes 'there can be no assurance that we will have the necessary capital resources to develop' the DMS plant. For a holder, that is a structural, recurring headwind: even if the project works, your stake keeps getting cut.